Pharmaceutical Biology · 2022 · 46 citations · 40 references
PharmacyPharmacologyToxicologyBiocompatibilityDrug DeliveryNanoparticle Drug DeliveryCell-nanoparticle InteractionsNanomaterials For Drug DeliveryNanomedicineNanoparticle CharacterizationNanoparticle FormulationsPolymeric NanoparticlesBiomedical ApplicationsCarbon Tetrachloride ToxicityChitosanChitosan-based NanomaterialsDrug-delivery ApplicationsImmunohistochemical StainingNanoparticlesRenoprotective Effects
CONTEXT: Chitosan is a biocompatible polysaccharide that has been widely exploited in biomedical and drug delivery applications. OBJECTIVE: in rats. MATERIALS AND METHODS: + chitosan NPs (10 and 20 mg/kg) orally for 2 weeks. The renoprotective effect was assessed by measuring oxidative, apoptotic, and inflammatory biomarkers, and via histopathological and immunohistochemical examinations for the visualization of NF-κB and COX-2 in renal tissues. RESULTS: ˂ 0.05) decrease in malondialdehyde levels (30.6%), tumour necrosis factor-α (33.6%), interleukin-1β (31.1%), and caspase-3 (36.6%). CONCLUSIONS: -induced nephrotoxicity. Thus, chitosan nanoparticles could afford a potential nanotherapeutic system for the management of nephrotoxicity which allows for broadening their role in biomedical delivery applications.
40
George L. Ellman · Archives of Biochemistry and Biophysics · 1959 · 26.2K citations
Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model
Jian-Qing Gao, Yulan Hu, Wang et al. · International Journal of Nanomedicine · 2011 · 282 citations · Full text
Pharmacy, Biotechnology, Toxicology +17